These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 10514356)

  • 1. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs.
    Serajuddin AT
    J Pharm Sci; 1999 Oct; 88(10):1058-66. PubMed ID: 10514356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
    Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
    Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
    Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vehicle amphiphilicity on the dissolution and bioavailability of a poorly water-soluble drug from solid dispersions.
    Serajuddin AT; Sheen PC; Mufson D; Bernstein DF; Augustine MA
    J Pharm Sci; 1988 May; 77(5):414-7. PubMed ID: 3411464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
    Vasconcelos T; Sarmento B; Costa P
    Drug Discov Today; 2007 Dec; 12(23-24):1068-75. PubMed ID: 18061887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosage form designs for the controlled drug release of solid dispersions.
    Tran PHL; Tran TTD
    Int J Pharm; 2020 May; 581():119274. PubMed ID: 32234566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET; Cadé D; Benameur H
    Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid dispersions: a review.
    Dhirendra K; Lewis S; Udupa N; Atin K
    Pak J Pharm Sci; 2009 Apr; 22(2):234-46. PubMed ID: 19339238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations.
    Srinarong P; de Waard H; Frijlink HW; Hinrichs WL
    Expert Opin Drug Deliv; 2011 Sep; 8(9):1121-40. PubMed ID: 21722000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative Manufacturing Concepts for Solid Oral Dosage Forms From Drug Nanosuspensions Using Fluid Dispensing and Forced Drying Technology.
    Bonhoeffer B; Kwade A; Juhnke M
    J Pharm Sci; 2018 Mar; 107(3):909-921. PubMed ID: 29154900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of poorly soluble compounds by amorphous solid dispersions.
    Lee TW; Boersen NA; Hui HW; Chow SF; Wan KY; Chow AH
    Curr Pharm Des; 2014; 20(3):303-24. PubMed ID: 23651395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Overview on Recent Patents and Technologies on Solid Dispersion.
    Kaushik R; Budhwar V; Kaushik D
    Recent Pat Drug Deliv Formul; 2020; 14(1):63-74. PubMed ID: 31951172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization of poorly water-soluble drugs using solid dispersions.
    Tran TT; Tran PH; Khanh TN; Van TV; Lee BJ
    Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):122-33. PubMed ID: 23244679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
    Vo CL; Park C; Lee BJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):799-813. PubMed ID: 24056053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances and patents in solid dispersion technology.
    Iqbal B; Ali A; Ali J; Baboota S; Gupta S; Dang S; Shadab M; Sahni JK
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):244-64. PubMed ID: 21834778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
    Bikiaris DN
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F; Gala U; Chauhan H
    Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The filling of molten and thixotropic formulations into hard gelatin capsules.
    Walker SE; Ganley JA; Bedford K; Eaves T
    J Pharm Pharmacol; 1980 Jun; 32(6):389-93. PubMed ID: 6106669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility.
    Tran PH; Tran TT; Lee KH; Kim DJ; Lee BJ
    Expert Opin Drug Deliv; 2010 May; 7(5):647-61. PubMed ID: 20205605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.